Quam outlines GHI at Global Health Council conference

Lois Quam, executive director of the Obama administration's Global Health Initiative (GHI), talked about GHI projects and "defended the program even if her panel was met with some hard questions" during a presentation on Tuesday at the annual Global Health Council conference in Washington, D.C., GlobalPost's "Global Pulse" blog reports.

Quam joined Lee Brudvig, deputy chief of mission in Kenya, and Jennifer Klein, special advisor for the Office of Global Health Women's Issues, on a panel that discussed the strategies GHI had implemented in the eight GHI plus countries of Bangladesh, Ethiopia, Guatemala, Kenya, Malawi, Mali, Nepal and Rwanda. Quam "emphasized that GHI had built on a strong foundation already in place through previous initiatives such as PEPFAR and the President's Malaria Initiative (PMI), but was founded on the idea that much more could be done," according to the blog. "However, what the panel lacked were the concrete specifics that showed GHI's progress in each country," the blog states, summarizing some of the questions the panel received (Karimjee, 6/14).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption